Top Manufacturing Companies in Dublin (53)
Pilot Photonics Ltd offers unique optical comb source subsystems that it develops as a platform technology applicable to many markets including communication, spectroscopy, sensing, and metrology. The company has deep IPR around the generation and application of optical combs which it couples with a powerful capability in photonic integration to produce the world's smallest and most versatile comb sources. Pilot...
Invert Robotics provides remote robotic inspection services with unprecedented levels of safety, accuracy and speed. Our main focus is in the Food Production, Chemicals, Pharmaceuticals, Aviation and Energy industries. This is not an everyday job, but a job where safety and accuracy are paramount. Besides this, Invert Robotics comes together with an agile and inventive work environment. At Invert Robotics,...
We enable Cardiologists to save lives through exceptional decision-making accuracy
Today, in our world, magnetic technologies are now universally used to charge, fuel & feed the planet. From Tesla Electric cars, magnetic levitation trains to MRI machines in the medical space. In this rapidly changing world, we too are changing & evolving. At the heart of this evolution lies our unrelenting pursuit of science-led, technology developments. To mark this evolution...
Atlas is a leading designer and manufacturer of autonomous UAV systems for professional use-cases, that works with a dominant defense, security, and infrastructure institutions in the U.S., the E.U., and Asia. Founded in the EU in 2015 by Aerospace and Robotics professionals with a vision to disrupt the UAV sphere, Atlas utilizes its proprietary and cost-effective technology to provides defense...
Ipsen is a French leading global mid-size biopharmaceutical company headquartered in Paris, France focusing its efforts where unmet medical needs are greatest. Ipsen develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Rare Disease and Neuroscience. We have over 5000 employees worldwide and our medicines are registered in more than 100 countries, with direct commercial presence in...
Ipsen's Top Stability & Growth Strengths
Strong Revenue Growth: Reported results show double-digit growth at constant exchange rates in 2024 and 2025 with an accelerated start in Q1 2026, and guidance indicates continued expansion in 2026. This momentum spans all three therapeutic areas rather than a single product.
Profitability: Disclosures highlight expanding core operating margins above the mid-30s and rising core operating income. Guidance continues to target strong margins alongside growth.
Diversified Revenue Streams: Recent updates indicate contributions from Oncology, Rare Disease, and Neuroscience, with products excluding Somatuline growing strongly and rare disease accelerating. Strategic acquisitions and partnerships have broadened the base beyond any single legacy brand.
Schneider Electric is your energy technology partner. We lead the convergence of electrification, automation, and digital intelligence to make the New Energy Landscape possible. Through platforms like EcoStruxure, we enable buildings, data centers, factories, infrastructure, and grids to operate as open, software-defined systems with intelligence built in at every level. We go beyond connectivity - simplifying complexity and unlocking the...
Schneider Electric's Top Stability & Growth Strengths
Strong Revenue Growth: Feedback suggests Schneider delivered record annual results, sustained strong organic growth into early 2026, and holds a sizable backlog that provides good visibility. Company commentary ties momentum to Energy Management and data‑center‑related systems.
Strong Market Position & Advantage: Feedback suggests the firm is widely viewed as a leader across energy management, data center power distribution, and grid/digital platforms, reinforced by independent leaderboards and repeated sustainability accolades. Competitive comparisons also cite strengths in service quality, integration, and overall culture versus key peers.
Market Expansion: Feedback suggests the company is actively investing and hiring, with major U.S. capacity expansions and thousands of open roles globally targeted at AI, data centers, and grid modernization. North America shows particularly strong traction alongside growth in other regions.
Sia Partners is a next generation management consulting firm and pioneer of Consulting 4.0. We offer a unique blend of AI and design capabilities, augmenting traditional consulting to deliver superior value to our clients. Counting 1,800 consultants in 18 countries, we expect to achieve USD 300 million in turnover for the current fiscal year. With a global footprint and expertise...
Sia Partners's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Recent investment by Blackstone of up to €250 million in December 2024 provides growth capital and signals external confidence in the firm’s expansion plans. Company statements link this funding to accelerating U.S. growth, M&A, and AI-enabled offerings.
Market Expansion: Multiple acquisitions and a sustained U.S. push (e.g., Notion Consulting, Ready Set Rocket, Precedence, Kaiser Associates) indicate ongoing geographic and service-line expansion across North America and Europe. Leadership attention to the U.S. market and a growing office footprint suggest increased depth in key geographies.
Innovation-Driven Growth: The firm is productizing AI (e.g., SiaGPT and 800+ deployable AI agents by April 2026) and launching new lines like Corporate Strategy, PE & M&A, pointing to growth via differentiated, tech-enabled delivery. Partnerships and ecosystem recognition around NVIDIA and AWS reinforce momentum in AI-driven consulting.
At Dyson we are focused on solving the problems that others have ignored; solving them first using our technology and ingenuity. In order to achieve this we need to pioneer technologies that are different and authentic. This is the core of what we do and who we are. We must strive to create the future, every single day by developing...
Dyson's Top Stability & Growth Strengths
Innovation-Driven Growth: Recent disclosures describe record product launches and stepped‑up R&D across robotics, motors, purifiers, and next‑generation batteries. Company filings and press updates note record unit volumes in 2024 and the most launches ever in 2025, highlighting technology-led momentum even as revenue softened.
Strong Market Position & Advantage: Market snapshots show Dyson leading premium tiers and holding top brand position in select geographies, such as being the No. 1 vacuum brand by retail volume in Germany. Its Supersonic, Airwrap, and Airstrait helped define the high-end of beauty hardware and shaped the category’s innovation agenda.
Product Line Growth: The pipeline expanded with 13 launches in 2025—the company’s largest wave—spanning floorcare, robotics, air purification, and beauty. Management emphasized continued investment to support a broader lineup and new categories.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...
ICON plc's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global CRO with significant scale and a broad geographic footprint, supported by a major acquisition that strengthened its competitive standing. Operational activity indicators and industry recognition are presented as reinforcing its ability to win and execute large, complex trials.
Profitability: Earnings and operating profit metrics are described as improving in 2024, with increases in GAAP net income, adjusted earnings per share, and adjusted EBITDA. These results suggest the business maintained solid margin performance even as quarterly revenue fluctuated.
Resilient & Sustainable Growth: A large backlog and a book-to-bill above 1.0 in 2024 are cited as providing multi-year revenue visibility and demand coverage. Continued backlog levels into 2025 are described as a stabilizing factor despite a softer near-term revenue trajectory.
Analog Devices, Inc. (NASDAQ: ADI) operates at the center of the modern digital economy, converting real-world phenomena into actionable insight with its comprehensive suite of analog and mixed signal, power management, radio frequency (RF), and digital and sensor technologies. ADI serves 125,000 customers worldwide with more than 75,000 products in the industrial, communications, automotive, and consumer markets. ADI is headquartered...
Analog Devices's Top Stability & Growth Strengths
Strong Market Position & Advantage: Analog Devices is positioned as a top-tier analog and mixed-signal semiconductor provider with leadership in key niches like data converters and a “premium position” in complex, high-performance analog. Its design-in “stickiness” in long-lifecycle systems is described as supporting predictable, long-term revenue.
Strong Revenue Growth: Recent results show a rebound and acceleration, including fiscal 2025 revenue growth versus 2024 and strong year-over-year growth in the most recent quarter with higher near-term revenue guidance. Forward-looking expectations also indicate continued expansion over the next several years.
Healthy Cash Flow: Cash generation is described as robust, with strong operating and free cash flow enabling sizable shareholder returns through dividends and repurchases. Ongoing dividend increases are presented as consistent with confidence in durable cash generation.
Perrigo Company plc, is a global consumer self-care company. Our vision is: To make lives better by bringing "Quality, Affordable Self-Care Products" that consumers trust everywhere they are sold. Founded in 1887 as a packager of home remedies, Perrigo has transformed to a self-company which enables the empowered consumer to treat conditions that can be self-managed. Perrigo is the world's largest...
Thermo Systems is a full-service control systems integration partner, providing world-class automation solutions within the Energy, Life Sciences, and Mission Critical markets. We excel at managing and delivering turnkey projects to our EPC & AE partners while also specializing in customized direct-to-owner solutions, focusing on industries where we can offer unmatched domain knowledge to deliver the best possible services and...
Plasma Bound provides a step-change technology, termed Controlled Polymer Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, by enabling reliable adhesive joining which is stronger than the composite structures themselves. The technology will satisfy the...
Drive incorporates four businesses in the Irish automotive technology space - Sweep, TradeBid, Nevo & InstaBid
TEAM Accessories (TA) is an independent aerospace MRO provider with overhaul capabilities on engine accessories, airframe components and airframe safety equipment. TA also have overhaul capabilities on a wide range of industrial gas turbine accessories and components servicing the oil & gas and energy sector. 25 years’ experience supporting a global customer base with bespoke service solutions. Certified Approvals: EASA/...
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments...
BioMarin Pharmaceutical Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Results show double‑digit revenue growth in 2025, with acceleration in Q4 driven by Voxzogo uptake and steady enzyme therapies across 55 markets. 2026 guidance points to a higher revenue range, indicating continued expansion.
Profitability: Disclosures highlight strong profitability with $828 million in 2025 operating cash flow and a targeted ~40% non‑GAAP operating margin for 2026 (excluding Amicus). Non‑GAAP EPS guidance of $4.95–$5.15 further signals operating leverage.
Diversified Revenue Streams: The portfolio spans multiple enzyme therapies and the achondroplasia franchise, and the pending Amicus acquisition would add Galafold and Pombiliti + Opfolda to diversify revenues from mid‑2026 onward. Enzyme therapies collectively grew in 2025, supporting breadth beyond a single asset.
Sublimity Therapeutics is a clinical-stage biotechnology company dedicated to identifying and developing meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases. Led by a team of industry innovators and leveraging our Single-Multiple Pill (SmPill®) technology, we are advancing a diverse pipeline of oral small molecules that have the potential to make important contributions to human health. Our...
Rakuten Kobo Inc. is the world’s only dedicated digital bookseller. Owned by Tokyo-based Rakuten and headquartered in Toronto, Kobo enables more than 30 million readers worldwide to read anytime, anywhere and on any device. With our award-winning eReaders and the free Kobo App for smartphones and tablets, Kobo is your portable reading world
WGNSTAR, formerly Westerwood Global and NSTAR Global Services, is a trusted partner to many of the world’s leading semiconductor manufacturers, providing innovative and cost-efficient managed workforce services and asset lifecycle management solutions. We partner with our clients to build a custom approach which ensures we deliver a workforce solutions plan that is tailored to their specific operations and ultimate business...
